APYX
Price
$0.99
Change
-$0.17 (-14.66%)
Updated
Apr 4 closing price
Capitalization
47.46M
32 days until earnings call
BSX
Price
$89.70
Change
-$8.80 (-8.93%)
Updated
Apr 4 closing price
Capitalization
100.1B
17 days until earnings call
Ad is loading...

APYX vs BSX

Header iconAPYX vs BSX Comparison
Open Charts APYX vs BSXBanner chart's image
Apyx Medical
Price$0.99
Change-$0.17 (-14.66%)
Volume$144.06K
Capitalization47.46M
Boston Scientific
Price$89.70
Change-$8.80 (-8.93%)
Volume$22.57M
Capitalization100.1B
APYX vs BSX Comparison Chart
Loading...
APYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APYX vs. BSX commentary
Apr 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APYX is a StrongBuy and BSX is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 07, 2025
Stock price -- (APYX: $0.99 vs. BSX: $89.70)
Brand notoriety: APYX: Not notable vs. BSX: Notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: APYX: 369% vs. BSX: 281%
Market capitalization -- APYX: $47.46M vs. BSX: $100.1B
APYX [@Medical Specialties] is valued at $47.46M. BSX’s [@Medical Specialties] market capitalization is $100.1B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APYX’s FA Score shows that 0 FA rating(s) are green whileBSX’s FA Score has 2 green FA rating(s).

  • APYX’s FA Score: 0 green, 5 red.
  • BSX’s FA Score: 2 green, 3 red.
According to our system of comparison, BSX is a better buy in the long-term than APYX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APYX’s TA Score shows that 4 TA indicator(s) are bullish while BSX’s TA Score has 4 bullish TA indicator(s).

  • APYX’s TA Score: 4 bullish, 6 bearish.
  • BSX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BSX is a better buy in the short-term than APYX.

Price Growth

APYX (@Medical Specialties) experienced а -23.85% price change this week, while BSX (@Medical Specialties) price change was -9.72% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -6.38%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -1.88%.

Reported Earning Dates

APYX is expected to report earnings on Aug 07, 2025.

BSX is expected to report earnings on Jul 23, 2025.

Industries' Descriptions

@Medical Specialties (-6.38% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BSX($100B) has a higher market cap than APYX($47.5M). BSX YTD gains are higher at: 0.425 vs. APYX (-37.342). BSX has higher annual earnings (EBITDA): 3.45B vs. APYX (-18.11M). BSX has more cash in the bank: 865M vs. APYX (43.7M). APYX has less debt than BSX: APYX (38.5M) vs BSX (9.49B). BSX has higher revenues than APYX: BSX (14.2B) vs APYX (52.3M).
APYXBSXAPYX / BSX
Capitalization47.5M100B0%
EBITDA-18.11M3.45B-1%
Gain YTD-37.3420.425-8,777%
P/E RatioN/A63.64-
Revenue52.3M14.2B0%
Total Cash43.7M865M5%
Total Debt38.5M9.49B0%
FUNDAMENTALS RATINGS
APYX vs BSX: Fundamental Ratings
APYX
BSX
OUTLOOK RATING
1..100
8675
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
83
Overvalued
PROFIT vs RISK RATING
1..100
1004
SMR RATING
1..100
9672
PRICE GROWTH RATING
1..100
8552
P/E GROWTH RATING
1..100
10027
SEASONALITY SCORE
1..100
504

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APYX's Valuation (56) in the Medical Specialties industry is in the same range as BSX (83). This means that APYX’s stock grew similarly to BSX’s over the last 12 months.

BSX's Profit vs Risk Rating (4) in the Medical Specialties industry is significantly better than the same rating for APYX (100). This means that BSX’s stock grew significantly faster than APYX’s over the last 12 months.

BSX's SMR Rating (72) in the Medical Specialties industry is in the same range as APYX (96). This means that BSX’s stock grew similarly to APYX’s over the last 12 months.

BSX's Price Growth Rating (52) in the Medical Specialties industry is somewhat better than the same rating for APYX (85). This means that BSX’s stock grew somewhat faster than APYX’s over the last 12 months.

BSX's P/E Growth Rating (27) in the Medical Specialties industry is significantly better than the same rating for APYX (100). This means that BSX’s stock grew significantly faster than APYX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APYXBSX
RSI
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
49%
MACD
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
54%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
43%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
45%
Advances
ODDS (%)
Bullish Trend 14 days ago
85%
Bullish Trend 6 days ago
63%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
45%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
86%
Aroon
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
43%
View a ticker or compare two or three
Ad is loading...
APYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SAFE17.70-0.11
-0.62%
Safehold
MAIA1.50-0.09
-5.66%
MAIA Biotechnology
EOG110.55-9.34
-7.79%
EOG Resources
BXSL29.20-2.49
-7.86%
Blackstone Secured Lending Fund
BVS8.33-0.82
-8.96%
Bioventus

APYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, APYX has been loosely correlated with CORBF. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if APYX jumps, then CORBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APYX
1D Price
Change %
APYX100%
-14.66%
CORBF - APYX
36%
Loosely correlated
+9.52%
MKEAF - APYX
33%
Loosely correlated
N/A
QDEL - APYX
30%
Poorly correlated
-13.42%
BSX - APYX
30%
Poorly correlated
-8.93%
AVGR - APYX
27%
Poorly correlated
N/A
More

BSX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BSX has been closely correlated with ISRG. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if BSX jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSX
1D Price
Change %
BSX100%
-8.93%
ISRG - BSX
68%
Closely correlated
-8.70%
SYK - BSX
61%
Loosely correlated
-6.07%
RVTY - BSX
52%
Loosely correlated
-5.87%
AORT - BSX
43%
Loosely correlated
-3.81%
MMSI - BSX
43%
Loosely correlated
-11.02%
More